These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Identification of potential Plk1 targets in a cell-cycle specific proteome through structural dynamics of kinase and Polo box-mediated interactions. Bibi N; Parveen Z; Rashid S PLoS One; 2013; 8(8):e70843. PubMed ID: 23967120 [TBL] [Abstract][Full Text] [Related]
6. Cancer Osaka thyroid (Cot) phosphorylates Polo-like kinase (PLK1) at Ser137 but not at Thr210. Wu B; Jiang P; Mu Y; Wilmouth RC Biol Chem; 2009 Dec; 390(12):1271-7. PubMed ID: 19804365 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity. Johnson EF; Stewart KD; Woods KW; Giranda VL; Luo Y Biochemistry; 2007 Aug; 46(33):9551-63. PubMed ID: 17655330 [TBL] [Abstract][Full Text] [Related]
12. Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Yang J; Cron P; Good VM; Thompson V; Hemmings BA; Barford D Nat Struct Biol; 2002 Dec; 9(12):940-4. PubMed ID: 12434148 [TBL] [Abstract][Full Text] [Related]
13. Screening and Identification of PLK1-Polo Box Binding Peptides by High-Throughput Sequencing of Phage-Selected Libraries. Bibi N; Niaz H; Hupp T; Kamal MA; Rashid S Protein Pept Lett; 2019; 26(8):620-633. PubMed ID: 30887917 [TBL] [Abstract][Full Text] [Related]
14. Molecular basis for the substrate specificity of NIMA-related kinase-6 (NEK6). Evidence that NEK6 does not phosphorylate the hydrophobic motif of ribosomal S6 protein kinase and serum- and glucocorticoid-induced protein kinase in vivo. Lizcano JM; Deak M; Morrice N; Kieloch A; Hastie CJ; Dong L; Schutkowski M; Reimer U; Alessi DR J Biol Chem; 2002 Aug; 277(31):27839-49. PubMed ID: 12023960 [TBL] [Abstract][Full Text] [Related]
15. A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1. Reindl W; Strebhardt K; Berg T Anal Biochem; 2008 Dec; 383(2):205-9. PubMed ID: 18793607 [TBL] [Abstract][Full Text] [Related]
16. Identification of phosphorylation sites in the polo-like kinases Plx1 and Plk1 by a novel strategy based on element and electrospray high resolution mass spectrometry. Wind M; Kelm O; Nigg EA; Lehmann WD Proteomics; 2002 Nov; 2(11):1516-23. PubMed ID: 12442251 [TBL] [Abstract][Full Text] [Related]
17. Universal quantitative kinase assay based on diagonal SCX chromatography and stable isotope dimethyl labeling provides high-definition kinase consensus motifs for PKA and human Mps1. Hennrich ML; Marino F; Groenewold V; Kops GJ; Mohammed S; Heck AJ J Proteome Res; 2013 May; 12(5):2214-24. PubMed ID: 23510141 [TBL] [Abstract][Full Text] [Related]
18. Multiplexed random peptide library and phospho-specific antibodies facilitate human polo-like kinase 1 inhibitor screen. Tanaka K; Koresawa M; Iida M; Fukasawa K; Stec E; Cassaday J; Chase P; Rickert K; Hodder P; Takagi T; Komatani H Assay Drug Dev Technol; 2010 Feb; 8(1):47-62. PubMed ID: 20085455 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation by LAMMER protein kinases: determination of a consensus site, identification of in vitro substrates, and implications for substrate preferences. Nikolakaki E; Du C; Lai J; Giannakouros T; Cantley L; Rabinow L Biochemistry; 2002 Feb; 41(6):2055-66. PubMed ID: 11827553 [TBL] [Abstract][Full Text] [Related]
20. Non-proteinogenic amino acids in the pThr-2 position of a pentamer peptide that confer high binding affinity for the polo box domain (PBD) of polo-like kinase 1 (Plk1). Qian WJ; Park JE; Lee KS; Burke TR Bioorg Med Chem Lett; 2012 Dec; 22(24):7306-8. PubMed ID: 23159568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]